Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7741 USD | +1.53% | +5.75% | -24.11% |
Business Summary
Number of employees: 6
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceuticals
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +144.15% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +144.15% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 67 | 31/12/04 | |
Jonathan Kaufman
CEO | Chief Executive Officer | 58 | 31/12/04 |
Douglas Johnston
DFI | Director of Finance/CFO | 40 | 30/09/21 |
Janet Okonski
CTO | Chief Tech/Sci/R&D Officer | - | 31/07/21 |
Joseph Janicki
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michelle Gruber
COO | Chief Operating Officer | - | 31/12/08 |
Katie Johnston
AUD | Comptroller/Controller/Auditor | - | - |
Allison Houck
PRN | Corporate Officer/Principal | - | - |
Tomohiro Ueda
PRN | Corporate Officer/Principal | - | - |
Robert Moldwin
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Kaufman
CEO | Chief Executive Officer | 58 | 31/12/04 |
Founder | 67 | 31/12/04 | |
Byong Kim
BRD | Director/Board Member | 54 | 28/02/22 |
Ryan Pruchnic
BRD | Director/Board Member | 50 | 31/08/21 |
Naoki Yoshimura
BRD | Director/Board Member | 67 | 31/08/21 |
Daniel Cohen
BRD | Director/Board Member | 60 | 20/03/23 |
Lori Birder
BRD | Director/Board Member | 64 | 16/06/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 7,605,636 | 4,530,361 ( 59.57 %) | 0 | 59.57 % |
Company contact information
Lipella Pharmaceuticals, Inc.
7800 Susquehanna Street Suite 505
15208, Pittsburgh
+412-901-0315
http://www.lipella.comSector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.11% | 5.8M | |
+8.57% | 114B | |
+10.55% | 104B | |
-12.71% | 22.41B | |
-0.32% | 22.28B | |
-5.75% | 19.07B | |
-37.36% | 18B | |
-5.68% | 17.89B | |
+6.98% | 14.28B | |
+36.59% | 12.55B |
- Stock Market
- Equities
- LIPO Stock
- Company Lipella Pharmaceuticals Inc.